FDA: COVID-19 Vaccine Needs To Be Administered As Authorized
Those who who receive the COVID-19 vaccine must get two full doses, the U.S. Federal Drug Administration said amid reports concerning altering how the drug can be administered.
The FDA issued the warning in a statement on Monday, stating it has been following reports about reducing the number of doses, extending the length of time between injections and reducing the size of each dose in order to inoculate more people, warning doing so may "run a significant risk of placing public health at risk."
"These are all reasonable questions to consider and evaluate in clinical trials," Stephen Hahn, commissioner of Food and Drugs at the FDA, and Peter Marks, director of the Center for Biologics Evaluation and Research, said in the joint statement. "However, at this time, suggesting changes to the FDA-authorized dosing or schedules of these vaccines is premature and not rooted solidly in the available evidence."
The two medical experts said they lack appropriate data to support changing how the vaccines were authorized to be administered.
The statement was issued a day after Moncef Slaoui, chief scientific adviser for the Trump administration's Operation Warp Speed vaccine program, told CNN on Sunday that the FDA was considering halving doses of Moderna's COVID-19 vaccine for those between the ages of 18 to 55 to increase the number of people who can be inoculated against the virus.
Hahn and Marks said the public needs to receive the vaccine as it was authorized by the FDA, stating researchers during clinical trials followed those who failed to receive their second shot only for a short period of time so there is not enough data to understand the depth or duration of protection one receives from a single dose of the vaccine.
"If people do not truly know how protective a vaccine is, there is the potential for harm because they may assume that they are fully protected when they are not, and accordingly, alter their behavior to taken unnecessary risks," they said.


Lamont says state on pace to meet vaccine goals
Democrats Call For National Coordinator To Oversee Vaccine Distribution
Advisor News
- Dutch gambling tax hike falls short as prediction markets eye World Cup
- Caregiving: A challenge that costs employers billions
- Could your practice benefit from an advisory board?
- SEC nears settlement with accused scammer Tai Lopez
- The 3 things that shrink your Social Security income
More Advisor NewsAnnuity News
- Globe Life Inc. (NYSE: GL) Highlighted for Surprising Price Action
- Trademark Application for “EMPOWER YOUR MONEY” Filed by Empower Annuity Insurance Company of America: Empower Annuity Insurance Company of America
- Built-in guaranteed annuities: What advisors should know
- Malibu Life Holdings Completes Acquisition of TruSpire, Establishing Malibu USA and Accelerating Entry into the U.S. Retail Annuity Market
- Why job boards are failing insurance agencies
More Annuity NewsHealth/Employee Benefits News
- NYC Expands Outreach to Help Residents Keep Health Coverage
- 'We have to be smart about it'
- Georgia can do more to protect health coverage for its youngest residents
- State budget helps 200,000 afford insurance
- State Health Plan brings back Blue Cross NC, approves Novant and UNC Health deals
More Health/Employee Benefits NewsLife Insurance News
- THINGS YOUR CLIENTS SHOULD KNOW BEFORE SELLING A LIFE INSURANCE POLICY
- Could your practice benefit from an advisory board?
- AM Best Revises Outlooks to Stable for Missouri Farm Bureau Group’s Members and Farm Bureau Life Insurance Company of Missouri
- Globe Life Inc. (NYSE: GL) Highlighted for Surprising Price Action
- AM Best Assigns Credit Ratings to China Ping An Insurance (Hong Kong) Company Limited
More Life Insurance News